Diabetic patients without health coverage: drug use, adherence and complications arising from their underlying disease
DOI:
https://doi.org/10.31052/1853.1180.v17.n2.6836Keywords:
diabetes mellitus, drug utilization studies, defined daily dose, programa Córdoba diabetes, diabetes complicationsAbstract
Objective: To carry out a drug usage study with diabetic patients treated at Josefina Prieur Hospital (HJP) Villa Allende city (Córdoba, Argentina) to determine anti-diabetic drug consumption, degree of treatment adherence, and amount of patients with complications arising from diabetes.
Method: Observational, descriptive, cross-sectional study carried out on diabetic patients treated at the HJP belonging to the program “Programa Córdoba Diabetes” (ProCorDia), from May to December 2011. Drug consumption was determined in DDDs per 1000 inhabitants per day. Adherence was defined by the number of drug provisions for each patient during eight months. The presence of complications was obtained from records of drug delivery to patients receiving other medication besides anti-diabetic ones.
Results: From 98 patients, 73 had some type of complication. The consumption of antidiabetic drugs in DDD per 1000 inhabitants per day was: Regular Insulin 1.990, NPH Insulin 6.244, Glibenclamide 2.826, Gliclazide 0.281, Metformin 2.497.
Conclusions: From all anti-diabetic drugs dispensed, 40.50% belonged to subgroup A10B (oral hypoglycemic agents) and 59.50% to subgroup A10A (insulin). Good adherence to drug therapy was observed (mean = 81.63%, mode = 100%). A 74.49% of patients presented complications.
Downloads
Downloads
Issue
Section
License
Copyright (c) 2014 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
How to Cite
